Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer

Cancer Discovery, Journal Year: 2021, Volume and Issue: 12(2), P. 303 - 330

Published: Dec. 10, 2021

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current or past history of cancer facing disparate consequences at every stage the trajectory. This comprehensive review offers a landscape analysis state literature on COVID-19 and cancer, including immune response to COVID-19, risk factors for severe disease, impact anticancer therapies. We also latest data treatment vaccination safety efficacy in as well care, urgent need rapid evidence generation real-world study designs. SIGNIFICANCE: Patients have faced journey due pandemic. field regarding cancer. cover response, implications care delivery. Overall, this provides an in-depth summary key issues during unprecedented health crisis.

Language: Английский

---

Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population

Breast Cancer Research and Treatment, Journal Year: 2022, Volume and Issue: 194(2), P. 475 - 482

Published: May 27, 2022

Language: Английский

---

Impact of COVID-19 on cancer screening: a global perspective

Current Opinion in Supportive and Palliative Care, Journal Year: 2022, Volume and Issue: 16(3), P. 102 - 109

Published: July 18, 2022

Purpose of review Cancer screening disruption due to COVID-19 may have a significant impact on patients, healthcare practitioners, and systems. In this present review, we aim offer comprehensive view the effect pandemic cancer programs worldwide. Recent findings The comprised 33 publications. During pandemic, rates investigations were drastically reduced Screening plummeted for all types cancer, ages, racial/ethnic groups. Reductions in percentages higher several underserved racial was suspended at least 30 days 13 countries. Summary Screenings fell sharply. chain management, delays any step are liable change outcome next step. Further long-term research will be needed fully comprehend services patient outcomes.

Language: Английский

---

Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic

eLife, Journal Year: 2023, Volume and Issue: 12

Published: May 2, 2023

The aftermath of the initial phase COVID-19 pandemic may contribute to widening disparities in colorectal cancer (CRC) outcomes due differential disruptions CRC screening. This comparative microsimulation analysis uses two CISNET models simulate impact ongoing screening induced by on long-term outcomes. We evaluate three channels through which was disrupted: delays screening, regimen switching, and discontinuation. these measured number life-years lost compared a scenario without any disruptions. While short-term 3-18 months are predicted result minor loss, discontinuing could much more significant reductions expected benefits These results demonstrate that unequal recovery following can widen emphasize importance ensuring equitable pandemic.

Language: Английский

---

Disparities in Cancer Stage Outcomes by Catchment Areas for a Comprehensive Cancer Center

JAMA Network Open, Journal Year: 2024, Volume and Issue: 7(5), P. e249474 - e249474

Published: May 2, 2024

The National Cancer Institute comprehensive cancer centers (CCCs) lack spatial and temporal evaluation of their self-designated catchment areas.

Language: Английский

---

Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity

JNCI Journal of the National Cancer Institute, Journal Year: 2022, Volume and Issue: 115(2), P. 139 - 145

Published: Sept. 6, 2022

Abstract The COVID-19 pandemic created unprecedented disruptions to routine health care in the United States. Screening mammography, a cornerstone of breast cancer control and prevention, was completely halted spring 2020, screening programs have continued face challenges with subsequent waves. Although mammography rates decreased for all women during pandemic, number studies now clearly documented that reductions been greater some populations than others. Specifically, minoritized screened at lower White across studies, although specific patterns disparity vary depending on communities studied. We posit these disparities are likely due variety structural contextual factors, including differential impact communities. also outline key considerations closing gaps mammography. First, practices, systems, must measure use identify whether exist which most affected. Second, we propose strategies close be multifaceted, targeting system or practice, but factors policy level. Health arise from complex set conditions, multimodal solutions address complex, multifactorial conditions lead may more succeed necessary promoting equity.

Language: Английский

---

Trends in uptake of cancer screening among people with severe mental illness before and after the COVID‐19 pandemic in Japan: A repeated cross‐sectional study

Psychiatry and Clinical Neurosciences Reports, Journal Year: 2025, Volume and Issue: 4(1)

Published: Feb. 2, 2025

Abstract Aim The aim of this study was to investigate trends in cancer screening participation among people with severe mental illness (PSMI) from periods before and after the COVID‐19 pandemic. Methods In repeated cross‐sectional study, we used anonymized datasets on municipal PSMI Okayama City. data covered fiscal year (FY) 2018 FY2022; database Medical Payment for Services Supports Persons Disabilities. were defined as those schizophrenia or related psychotic disorders (F20–29) bipolar disorder (F30 F31), identified using International Classification Diseases , Tenth Revision, codes. analysis included men women aged 40–69 years colorectal lung screening; 50–69 gastric breast 20–69 cervical screening. Municipal rates calculated each FY. Results For all types, FY2020 (colorectal: 9.0%; lung: 11.6%; gastric: 4.9%; breast: 6.2%; cervical: 6.1%) lower than FY2019 (11.5%, 14.0%, 6.5%, 9.3%, 8.3%, respectively). FY2022, (9.9%, 12.9%; 5.3%; 8.0%, 6.9%, respectively) recovered, but remained low. Conclusion This showed that very low, both Efforts encourage population are urgently needed.

Language: Английский

---

Patient-Reported Experiences of Breast Cancer Screening, Diagnosis, and Treatment Delay, and Telemedicine Adoption during COVID-19

Current Oncology, Journal Year: 2022, Volume and Issue: 29(8), P. 5919 - 5932

Published: Aug. 20, 2022

Purpose: To evaluate and quantify potential sociodemographic disparities in breast cancer screening, diagnosis, treatment due to the COVID-19 pandemic, use of telemedicine. Methods: We fielded a 52-item web-based questionnaire from 14 May 2020 1 July partnership with several U.S.-based advocacy groups. Individuals aged 18 or older were eligible for this study if they: (1) received routine screening; OR (2) undergoing diagnostic evaluation cancer; (3) had ever been diagnosed cancer. used descriptive statistics understand extent care delay telemedicine adoption multivariable logistic regression models estimate association factors odds COVID-19-related delays use. Results: Of 554 survey participants, 493 provided complete data on demographic socioeconomic included analysis. Approximately half (n = 248, 50.3%) personal history Overall, 188 (38.1%) participants experienced any including treatment, 339 (68.8) reported having at least one virtual appointment during period. Compared other insurance types, Medicaid 2.58 times more likely report (OR 2.58, 95% Cl: 1.05, 6.32; p 0.039). household income less than USD 50,000, those 150,000 2.38 2.38, 1.09, 5.17; 0.029) adopt appointments. Self-insured 70% compared categories 0.28, 0.11, 0.73; 0.009). Conclusions: The pandemic has significant impact accelerated delivery care. Lower-income groups patients certain such as self-insured could be experience Careful attention must paid vulnerable insure equity cancer-related service utilization access beyond pandemic.

Language: Английский

---

Disparities in lung cancer

Journal of the National Medical Association, Journal Year: 2023, Volume and Issue: 115(2), P. S46 - S53

Published: May 1, 2023

Language: Английский

---

Impact of the COVID-19 pandemic on human papillomavirus (HPV) vaccination among a national sample of United States adults ages 18–45: A cross-sectional study

Preventive Medicine Reports, Journal Year: 2022, Volume and Issue: 31, P. 102067 - 102067

Published: Nov. 21, 2022

To assess how the COVID-19 pandemic affected catch-up HPV vaccination among age-eligible adults (ages 18–45). The current study leverages a national, cross-sectional sample of US ages 18–45 years to prevalence and determinants pandemic-related disruptions in 2021. was restricted intending receive vaccine. Multinomial logistic regression analysis conducted probability 1) disruption 2) uncertainty about disruption. Report 'no disruption' served as reference category. Among get vaccine (n = 1,683), 8.6 % reported disruption, 14.7 76.7 no Factors associated with higher odds included non-English language preference (OR: 3.20; 95 CI: 1.99–5.13), being parent/guardian 1.77; 1.18–2.66), having at least one healthcare visit past year 1.97; 1.10–3.53), up-to-date on tetanus 1.81; 1.19–2.75), cancer survivor 2.57; 1.52–4.34). Catch-up for is critical public health strategy reducing HPV-related cancers. While small percentage vaccination, certain (e.g., individuals survivors) were more likely report Interventions may be needed that increase accessibility populations reduced access during pandemic.

Language: Английский

---